Reaction profile

The FDA adverse-event record for injection site neoplasm nos

32 FDA reports name injection site neoplasm nos, a lower-volume reaction in the CVM extract (VeDDRA 1879). Plate stamps and neighbourhood peers follow.

#1961 of 2,481
by report volume (all reactions)
32
reports citing this reaction
34.4%
death-coded share
Cat
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Injection site neoplasm NOS has 32 reports now versus 32 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Injection site neoplasm NOS changes

FDA AER · VeDDRA plate

Code 1879 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 32 reports
  • DEATH-HOT 34.4%
  • LOWER-Q #1961/2481
  • PHOTO-FINISH ANION GAP HI, BLD
  • SPECIES-CAT Cat · 20
  • DRUG-LEAD Cefovecin Sodium · 5
  • DESK-WIDE 15 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: ANION GAP HI, BLD (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Injection site neoplasm NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348ANION GAP HI, BLD · near32Application site haem… · near32Convulsive disorder N… · near32Copper toxicity signs · near32Injection site neopla… · thi…32Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Injection site neoplasm NOS

Injection site neoplasm NOS: high death-coded share in the FDA AER plate

Signature read: Injection site neoplasm NOS's 34.4% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 32 named reports in the openFDA extract. Death-coded share is upper-third: 11 of 32 reports (34.4% of named reports). Nearest volume peer: ANION GAP HI, BLD (±0 reports). Lead species Cat (20). Lead co-reported drug Cefovecin Sodium (5).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 20
Dog 12

Breeds Most Affected

Domestic (unspecified) 12
Domestic Shorthair 6
Dog (unknown) 2
Siamese 1
Crossbred Canine/dog 1
Mastiff 1
Siberian Husky 1
Shih Tzu 1
Bulldog - French 1
Corgi (unspecified) 1

Associated Drugs

Cefovecin Sodium 5
Moxidectin 5
Meloxicam 3
Cefovecin 3
Bedinvetmab 3
Carprofen 2
Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus 2
Buprenorphine 2
Robenacoxib 2
Maropitant Citrate 2
Ropivacaine 2
Glycosaminoglycan Polysulfate 1
Triamcinolone Acetonide 1
Butorphanol Tartrate 1
Tiletamine, Zolazepam 1
Dexmedetomidine Hydrochloride 1
Ivermectin 1
Ampicillin Trihydrate 1
Device: Microchip For Identification And Tracking Purposes 1
Anesthetic 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Injection site neoplasm NOS (#1961 of 2,481 by report volume); death-coded 34.4%. PlainBreed reaction plate · death-coded share stamp 34.4% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →